Matthias Simon

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial

Wolfgang Wick, Michael Platten, Christoph Meisner et al. · The Lancet Oncology · 2012 · 1.1K citations · Full text

Neuro-oncology, Temozolomide Chemotherapy, Malignant Astrocytoma +9

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

Christian Hartmann, Bettina Hentschel, Wolfgang Wick et al. · Acta Neuropathologica · 2010 · 837 citations

Unfavorable Prognostic Effect, Neuro-oncology, Tumor Heterogeneity +12

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

Felix Sahm, Daniel Schrimpf, Damian Stichel et al. · The Lancet Oncology · 2017 · 814 citations · Full text

Chromatin, Mendelian Disorder, Dna Methylation-based Classification +12

Genome-wide association study identifies five susceptibility loci for glioma

Sanjay Shete, Fay J. Hosking, Lindsay B. Robertson et al. · Nature Genetics · 2009 · 784 citations

Genome-wide Association Study, Genetics, Genetic Epidemiology +4

Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network

Michael Weller, Jörg Felsberg, Christian Hartmann et al. · Journal of Clinical Oncology · 2009 · 606 citations · Full text